BERGENBIO ASA revenue for the last year amounted to 200.00 k NOK, the most of which — 354.00 k NOK — came from its highest performing source at the moment, Innovative Drugs, the year earlier bringing 389.00 k NOK. The greatest contribution to the revenue figure was made by Norway — last year it brought BERGENBIO ASA 354.00 k NOK, and the year before that — 389.00 k NOK.